Combined Results of Two Cross-Sectional Surveys on the Participation in Clinical Trials and the e-Consent Procedure in the Landscape of Haematology.
clinical trial barriers
clinical trial enrolment
clinical trials
e-consent
patient-reported outcome
physician-reported outcome
Journal
Clinics and practice
ISSN: 2039-7275
Titre abrégé: Clin Pract
Pays: Switzerland
ID NLM: 101563282
Informations de publication
Date de publication:
23 Nov 2023
23 Nov 2023
Historique:
received:
26
09
2023
revised:
07
11
2023
accepted:
22
11
2023
medline:
22
12
2023
pubmed:
22
12
2023
entrez:
22
12
2023
Statut:
epublish
Résumé
Despite the motivation of oncology patients to take part in clinical trials, only a minority of them are enrolled in clinical trials. Implementation of new practical procedures can become a barrier that withholds patients from participating in clinical trials. Treating physicians are crucial in augmenting trial accrual. The drivers that promote physicians to allocate patients for clinical trials need further assessment. We conducted two separate cross-sectional surveys, addressing patients with a haematological disease in one survey and haematologists in another survey. The patient survey was filled out by 420 patients. Significant relationships between the willingness to participate in a trial and trial knowledge (
Identifiants
pubmed: 38131682
pii: clinpract13060133
doi: 10.3390/clinpract13060133
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1520-1531Subventions
Organisme : Novartis (Belgium)
ID : ON410REV